Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more
Horizon Lines: A Quarterly Review of NDAs – January-March, 2026
The NDAs approved during the first quarter of 2026 have been divided into the dosage forms Injection, Tablets, Capsules, Oral solution, Gas, and other. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed ... read more
Fortrea Agrees to $45M Purchase of Worldwide Early-Phase Unit
Thursday, September 03, 2026
Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 ... read more
Northway Biotech Opens $72 Million Cell-Therapy CDMO in Vilnius
Thursday, September 03, 2026
Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania... read more
ARPA-H Awards Up to $125M for Distributed RNA Medicine Manufacturing
Thursday, September 03, 2026
The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing ... read more
Evonik Invests $109 Million in Vancouver Lipid Drug Facility
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in ... read more